Clinical Trials
Learn More

Patient information on
AVAX's Phase III
Registration Study MVALDI

Clinical News

AVAX Announces Settlement Agreement with Cancer Treatment Centers of America and Approves $45 Million Private Placement Financing

AVAX Technologies Announces Expansion of Clinical Study with Autologous Ovarian Cancer Vaccine (OVax®)

© 2015 AVAX Technologies, Inc. | Terms
Site design: Schenkel/Stegman
Management Board of Directors Fact Sheet (pdf)
Product Pipeline & Overview Publications

Overview SEC Filings Information Request Press Releases
Home | Site Map | Contact Us